Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer | Synapse
February 13, 2026Open Access
Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer
Puntos clave
This study aims to explore the role of eRNAs in prostate cancer biology and identify potential aberrant pathways.
Analyzed the eRNA landscape in prostate cancer samples.
Investigated the association of eRNAs with cancer pathways.
Examined the potential prognostic value of eRNAs in prostate cancer.
Identified specific eRNAs associated with prostate cancer progression.
Showed that certain eRNAs can serve as biomarkers for prognosis.
Revealed aberrant pathways linked to the expression of eRNAs in prostate cancer.
Resumen
These findings indicate that eRNAs may contribute to prostate cancer biology and could serve as useful markers for prognosis and pathway characterization.